Catabasis Pharmaceuticals Shares March Newsletter

March 26, 2020

Catabasis Pharmaceuticals has released their March newsletter containing information that addressing questions regarding edasalonexent and COVID-19. Please find their frequently asked questions below and the full Catabasis Connection newsletter here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open